Innospec [IOSP] vs Stepan Company [SCL] Detailed Stock Comparison

Innospec Inc.

NASDAQ
Loading...

Stepan Company

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Innospec Inc. wins in 15 metrics, Stepan Company wins in 6 metrics, with 0 ties. Innospec Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Innospec Inc. Stepan Company Better
P/E Ratio (TTM) 16.05 19.21 Innospec Inc.
Price-to-Book Ratio 1.40 0.89 Stepan Company
Debt-to-Equity Ratio 3.95 58.20 Innospec Inc.
PEG Ratio -0.10 1.01 Stepan Company
EV/EBITDA 8.14 8.89 Innospec Inc.
Profit Margin (TTM) 6.56% 2.57% Innospec Inc.
Operating Margin (TTM) 10.32% 3.06% Innospec Inc.
EBITDA Margin (TTM) 10.32% 3.06% Innospec Inc.
Return on Equity 9.15% 4.77% Innospec Inc.
Return on Assets (TTM) 5.47% 2.05% Innospec Inc.
Free Cash Flow (TTM) $62.80M $39.28M Innospec Inc.
Dividend Yield 3.27% 3.20% Innospec Inc.
1-Year Return 2.15% 0.11% Innospec Inc.
Price-to-Sales Ratio (TTM) 1.05 0.49 Stepan Company
Enterprise Value $1.62B $1.74B Stepan Company
EV/Revenue Ratio 0.91 0.77 Stepan Company
Gross Profit Margin (TTM) 27.96% 12.09% Innospec Inc.
Revenue per Share (TTM) $71 $99 Stepan Company
Earnings per Share (Diluted) $4.67 $2.54 Innospec Inc.
Beta (Stock Volatility) 0.88 0.96 Innospec Inc.
Short % of Float 2.24% 2.65% Innospec Inc.

Innospec Inc. vs Stepan Company Stock Performance Analysis

Loading Price Chart...

IOSP
SCL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Innospec Inc.-1.71%4.58%8.91%24.94%8.59%11.58%
Stepan Company-0.02%5.91%10.73%15.99%13.01%15.50%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Innospec Inc.2.15%-14.33%-5.42%82.80%179.23%647.75%
Stepan Company0.11%-43.66%-55.74%-9.12%65.09%241.57%

Performance & Financial Health Analysis: Innospec Inc. vs Stepan Company

MetricIOSPSCL
Market Information
Market Cap i$1.91B$1.11B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i173,538166,590
90 Day Avg. Volume i269,069190,690
Last Close$85.11$54.47
52 Week Range$65.51 - $92.14$41.82 - $68.00
% from 52W High-7.63%-19.90%
All-Time High$133.71 (May 06, 2024)$139.30 (May 10, 2021)
% from All-Time High-36.35%-60.90%
Growth Metrics
Quarterly Revenue Growth-0.02%0.07%
Quarterly Earnings Growth-0.02%0.19%
Financial Health
Profit Margin (TTM) i0.07%0.03%
Operating Margin (TTM) i0.10%0.03%
Return on Equity (TTM) i0.09%0.05%
Debt to Equity (MRQ) i3.9558.20
Cash & Liquidity
Book Value per Share (MRQ)$53.52$54.90
Cash per Share (MRQ)$11.81$3.93
Operating Cash Flow (TTM) i$138.30M$109.13M
Levered Free Cash Flow (TTM) i$17.50M$-18,496,500
Dividends
Last 12-Month Dividend Yield i3.27%3.20%
Last 12-Month Dividend i$2.50$1.58

Valuation & Enterprise Metrics Analysis: Innospec Inc. vs Stepan Company

MetricIOSP (Apr 24, 2026)SCL (Oct 04, 2025)
Price Ratios
P/E Ratio (TTM) i16.0519.21
Forward P/E i11.9911.99
PEG Ratio i-0.101.01
Price to Sales (TTM) i1.050.49
Price to Book (MRQ) i1.400.89
Market Capitalization
Market Capitalization i$1.91B$1.11B
Enterprise Value i$1.62B$1.74B
Enterprise Value Metrics
Enterprise to Revenue i0.910.77
Enterprise to EBITDA i8.148.89
Risk & Other Metrics
Beta i0.880.96
Book Value per Share (MRQ) i$53.52$54.90

Financial Statements Comparison: Innospec Inc. vs Stepan Company

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricIOSP (2025)SCL (2024)
Revenue/Sales i1.78B2.18B
Cost of Goods Sold i1.29B1.91B
COGS % of Revenue i72.3%87.5%
Gross Profit i492.40M272.21M
Gross Margin i27.7%12.5%
Research & Development i51.00M55.67M
Operating Income (EBIT) i156.30M70.83M
Operating Margin i8.8%3.2%
EBITDA i225.00M188.92M
EBITDA Margin i12.7%8.7%
Pre-Tax Income i138.10M60.44M
Pre-Tax Income % of Revenue i7.8%2.8%
Income Tax i21.50M10.07M
Income Tax % of Revenue i1.2%0.5%
Net Income (Profit) i116.60M50.37M
Profit Margin i6.6%2.3%

Balance Sheet & Liquidity Metrics

MetricIOSP (2025)SCL (2024)
Cash & Equivalents i292.50M99.67M
Total Current Assets i1.00B810.43M
Total Current Assets % of Revenue i56.5%37.2%
Total Current Liabilities i360.10M669.03M
Total Current Liabilities % of Revenue i20.3%30.7%
Long-Term Debt i36.80M390.02M
Long-Term Debt % of Revenue i2.1%17.9%
Total Shareholders Equity i1.33B1.17B
Retained Earnings i1.10B1.27B
Retained Earnings % of Revenue i61.8%58.4%
Property, Plant & Equipment i561.60M71.48M

Cash Flow Statement Comparison

MetricIOSP (2025)SCL (2024)
Operating Cash Flow i113.80M129.25M
Operating Cash Flow % of Revenue i6.4%5.9%
Capital Expenditures i1.10MN/A
Free Cash Flow i62.80M39.28M
FCF Margin i3.5%1.8%
Debt Repayment i0-48.57M
Common Stock Repurchase i-23.90M0

Short Interest & Institutional Ownership Analysis

MetricIOSPSCL
Shares Short i403,648398,886
Short Ratio i1.392.08
Short % of Float i2.24%2.65%
Shares Outstanding i24.78M22.50M
Float Shares i24.47M21.44M
% Held by Insiders i1.34%4.61%
% Held by Institutions i101.55%85.74%
% Held by Public i-2.89%9.65%

Dividend Analysis & Yield Comparison: Innospec Inc. vs Stepan Company

MetricIOSPSCL
Last 12-Month Dividend i$2.50$1.58
Last 12-Month Dividend Yield i3.27%3.20%
3-Year Avg Annual Dividend i$1.77$1.53
3-Year Avg Dividend Yield i0.77%0.58%
3-Year Total Dividends i$5.32$4.60
Ex-Dividend DateNov 18, 2025Mar 02, 2026